TraceLink unveils Automated Validation Manager
Removes burden of validating software updates for Life Sciences Cloud customers.
TraceLink has launched Automated Validation Manager (AVM) – a revolutionary web-based offering that automates the entire validation lifecycle of the TraceLink Life Sciences Cloud on an ongoing basis.
Customers using the Life Sciences Cloud already benefit from the only network-tenant solution that enables them to quickly adapt to rapid change in today’s continuously evolving regulatory environment. By subscribing to TraceLink AVM, customers no longer have to deploy manual, labor-intensive, paper-based validation procedures and instead are assured that their current instance of the Life Sciences Cloud is automatically validated to meet GxP compliance requirements in accordance with industry standards, such as GAMP 5. Using nothing more than a browser, TraceLink AVM customers simply login to a web portal and review any aspect of the validation lifecycle, including the validation plan, traceability matrix, test results and final validation certificates. Once validation is complete, TraceLink AVM customers will know that all required IQ, OQ, and PQ test scripts have been successfully executed in a dedicated validation environment.
“We introduced our network-tenant Life Sciences Cloud platform in 2009 as a revolutionary architecture that would enable life sciences companies in any geographic market to eliminate the risks associated with frequent technology updates resulting from continuously changing laws, data exchange requirements and trade partner demands,” said Shabbir Dahod, president and CEO of TraceLink. “Automated Validation Manager is the next step in managing the complexity of computer systems validation for our customers, ensuring that they have an easy-to-use solution that removes the business and operational burdens of manual validation and keeps them continuously compliant.”
TraceLink Automated Validation Manager: How It Works
As regulatory demands evolve and changes occur, life sciences companies must be able to quickly adapt their track and trace solutions in order to maintain continuous compliance and prevent disruption to product flow. Technology solutions must also evolve to keep pace with these industry changes, and life sciences companies need to validate software updates to mitigate operational risk by confirming that all new software functionality is working as intended. With the unpredictability associated with pharmaceutical supply chain compliance, companies face the challenge of managing and validating software updates more frequently – often resulting in the need for specific staff expertise and repeated labor intensive testing. Those who outsource validation because they do not have in-house expertise face high costs for consultants to manage the entire validation process for them.
TraceLink AVM removes both the in-house and outsourcing burdens of validation by automating validation testing and confirming that current TraceLink software capabilities perform as intended. The end result is a fully executed, 100% paperless package compliant with GxP compliance standards, such as GAMP 5. Every TraceLink AVM customer will benefit from
TraceLink AVM is expected to be available by the third quarter of 2017 for TraceLink customers.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance